EKSO

MKT CAP:$27M

Ekso Bionics Holdings, Inc.

Market Cap

$27M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$10.67+$2.83 (+36.10%)

Apr 23, 2026

Company Details

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. Th...

CEO

Scott G. Davis

IPO Date

Jan 17, 2014

Website

www.eksobionics.com

Key Metrics TTM

Revenue

$13M

-28.6% YoY

Net Income

-$12M

EPS (Diluted)

-$3.46

Free Cash Flow

-$12M

Revenue / Share

$5.28

Gross Margin

53.5%

Operating Margin

-104.1%

Net Margin

-91.4%

FCF Margin

-92.2%

P/S

2.1x

P/E

—

Earnings Reports

Q1 2026

May 4, 2026

PENDING

FY 2025

Feb 23, 2026

$13M-28.6%EPS -$4.91

Q4 2025

Feb 23, 2026

$3M-38.3%EPS -$1.57

Q3 2025

Oct 28, 2025

$4M+2.4%EPS -$0.54

Q2 2025

Jul 28, 2025

$2M-58.4%EPS -$1.24

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$3M	$1M	-$4M
Q2 22	$3M	$2M	-$3M
Q3 22	$3M	$2M	-$4M
Q4 22	$4M	$2M	-$4M
Q1 23	$4M	$2M	-$4M
Q2 23	$5M	$2M	-$4M
Q3 23	$5M	$2M	-$3M
Q4 23	$5M	$2M	-$3M
Q1 24	$4M	$2M	-$3M
Q2 24	$5M	$3M	-$2M
Q3 24	$4M	$2M	-$3M
Q4 24	$5M	$3M	-$2M
Q1 25	$3M	$2M	-$3M
Q2 25	$2M	$819.0K	-$4M
Q3 25	$4M	$3M	-$1M
Q4 25	$3M	$2M	-$5M

Valuation

Quarter	P/S	P/E
Q1 22	46.0x	—
Q2 22	26.0x	—
Q3 22	23.2x	—
Q4 22	20.9x	—
Q1 23	22.5x	—
Q2 23	18.7x	—
Q3 23	8.9x	—
Q4 23	37.2x	—
Q1 24	20.1x	—
Q2 24	17.4x	—
Q3 24	24.2x	—
Q4 24	12.6x	—
Q1 25	8.8x	—
Q2 25	5.7x	—
Q3 25	0.8x	—
Q4 25	1.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$4M	-$4M
Q2 22	-$4M	-$4M
Q3 22	-$3M	-$3M
Q4 22	-$4M	-$4M
Q1 23	-$4M	-$4M
Q2 23	-$3M	-$3M
Q3 23	-$3M	-$3M
Q4 23	-$2M	-$2M
Q1 24	-$3M	-$3M
Q2 24	-$3M	-$3M
Q3 24	-$2M	-$2M
Q4 24	-$1M	-$1M
Q1 25	-$2M	-$2M
Q2 25	-$3M	-$3M
Q3 25	-$2M	-$2M
Q4 25	-$4M	-$4M

Capital Expenditures

Quarter	CapEx
Q1 22	$0
Q2 22	$0
Q3 22	$141.0K
Q4 22	$53.0K
Q1 23	$42.0K
Q2 23	$55.0K
Q3 23	$17.0K
Q4 23	$43.0K
Q1 24	$8.0K
Q2 24	$0
Q3 24	$8.0K
Q4 24	$21.0K
Q1 25	$0
Q2 25	$0
Q3 25	$50.0K
Q4 25	$50.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+34.4%	+34.8%
Q2 22	+56.7%	+20.4%
Q3 22	+9.2%	+19.6%
Q4 22	-12.9%	-7.4%
Q1 23	+60.6%	+26.0%
Q2 23	+35.7%	+34.3%
Q3 23	+38.4%	+7.9%
Q4 23	+36.5%	+3.9%
Q1 24	-8.9%	-18.2%
Q2 24	+5.3%	-18.9%
Q3 24	-10.4%	-10.2%
Q4 24	+5.0%	-11.8%
Q1 25	-10.1%	-2.8%
Q2 25	-58.4%	-17.2%
Q3 25	+2.4%	-16.8%
Q4 25	-38.3%	+4.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$563.0K	21.9%
Q2 22	$621.0K	17.9%
Q3 22	$581.0K	17.5%
Q4 22	$967.0K	27.2%
Q1 23	$517.0K	12.5%
Q2 23	$640.0K	13.6%
Q3 23	$526.0K	11.4%
Q4 23	$553.0K	11.4%
Q1 24	$405.0K	10.8%
Q2 24	$368.0K	7.4%
Q3 24	$470.0K	11.4%
Q4 24	$387.0K	7.6%
Q1 25	$225.0K	6.7%
Q2 25	$207.0K	10.1%
Q3 25	$259.0K	6.1%
Q4 25	$758.0K	24.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$921.0K	$3M	$2M
Q2 22	$873.0K	$2M	$2M
Q3 22	$887.0K	$3M	$2M
Q4 22	$771.0K	$3M	$2M
Q1 23	$1M	$3M	$2M
Q2 23	$1M	$3M	$2M
Q3 23	$1M	$2M	$2M
Q4 23	$1M	$3M	$2M
Q1 24	$1M	$2M	$2M
Q2 24	$1M	$2M	$2M
Q3 24	$777.0K	$2M	$2M
Q4 24	$845.0K	$2M	$2M
Q1 25	$988.0K	$3M	$2M
Q2 25	$852.0K	$2M	$2M
Q3 25	$550.0K	$2M	$1M
Q4 25	$641.0K	$3M	$2M

Revenue Segments

Quarter	Ekso Health	Ekso Works	Product	Product and Service, Other	Service	Subscription
Q2 22	$3M	$237.0K	—	—	—	—
Q3 22	$3M	$105.0K	—	—	—	—
Q4 22	$3M	$54.0K	—	—	—	—
Q1 23	$4M	$125.0K	—	—	—	—
Q3 23	—	—	$4M	$56.0K	$726.0K	$245.0K
Q1 24	—	—	$3M	$94.0K	$765.0K	$144.0K
Q2 24	—	—	$4M	$153.0K	$836.0K	$146.0K
Q3 24	—	—	$3M	$195.0K	$691.0K	$123.0K

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$36M	$0	$36M
Q2 22	$32M	$0	$32M
Q3 22	$29M	$0	$29M
Q4 22	$21M	$0	$21M
Q1 23	$16M	$0	$16M
Q2 23	$13M	$0	$13M
Q3 23	$10M	$0	$10M
Q4 23	$9M	$0	$9M
Q1 24	$9M	$0	$9M
Q2 24	$6M	$0	$6M
Q3 24	$8M	$0	$8M
Q4 24	$6M	$0	$6M
Q1 25	$8M	$0	$8M
Q2 25	$5M	$0	$5M
Q3 25	$3M	$0	$3M
Q4 25	$1M	$0	$1M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	13M	+0.4%	+18.4%
Q2 22	13M	+1.2%	+1.2%
Q3 22	13M	+1.5%	+2.8%
Q4 22	13M	+0.7%	+3.8%
Q1 23	13M	+1.0%	+4.5%
Q2 23	14M	+2.6%	+5.8%
Q3 23	14M	+3.2%	+7.7%
Q4 23	14M	+2.7%	+9.8%
Q1 24	17M	+20.6%	+31.0%
Q2 24	18M	+4.6%	+33.6%
Q3 24	20M	+11.4%	+44.3%
Q4 24	25M	+21.3%	+70.6%
Q1 25	25M	+3.1%	+45.8%
Q2 25	2M	-91.4%	-88.0%
Q3 25	3M	+20.0%	-87.1%
Q4 25	2M	-7.3%	-90.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$45.8K	56
Q2 22	$61.9K	56
Q3 22	$59.4K	56
Q4 22	$48.6K	73
Q1 23	$56.5K	73
Q2 23	$64.4K	73
Q3 23	$63.1K	73
Q4 23	$69.2K	70
Q1 24	$53.7K	70
Q2 24	$70.7K	70
Q3 24	$59.0K	70
Q4 24	$83.4K	61
Q1 25	$55.3K	61
Q2 25	$33.7K	61
Q3 25	$69.3K	61
Q4 25	$62.8K	50

Revenue / Employee